Wound care dressing, hemostatic gauze, Hemoblock
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- wound care dressing, hemostatic
- Category
- Wound Dressing Equipments
Incore Co.,Ltd.
- Country / Year Established
-
South Korea
/
2014
- Business type
- Manufacturer
- Verified Certificate
-
5
| Product name | Wound care dressing, hemostatic gauze, Hemoblock | Certification | - |
|---|---|---|---|
| Category | Wound Dressing Equipments | Ingredients | - |
| Keyword | wound care dressing , hemostatic | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
Wound care dressing, hemostatic gauze, Hemoblock
│ DESCRIPTION │
It is used to manage bleeding such as hemostasis by applying physical pressure to local wounds such
as cuts, lacerations and abrasions, and wounds of curved and three-dimensional body parts.
It can also be used for surgical and postoperative dermatology surgical wounds and temporary
treatment of severe bleeding.
It is a chitosan dressing for the management of bleeding that forms, coagulates and causes local hemostasis.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- KIM DONG TAK
- Address
- Hyeoksin daero 78gil 11, Dong-gu, Daegu, Korea
- Product Category
- Wound Dressing Equipments
- Year Established
- 2014
- Company introduction
-
INCORE CO., LTD offers safe disposable medical devices (Core-Forcep, Core- Clip, Core-Knife, Core-Snare, Core-Injector, Core-HotBiopsy) with no risk of infection, and hemostatic gauze ,HEMOBLOCK for topical hemostasis. We produce a variety of medical devices and medical supplies. Beyond the manufacture of medical devices, we research and develop products that reflect the requirements of medical specialists. Differentiated competitiveness based on R&D leads the development of endoscopic medical devices. We have grown into a company with a promising future. In addition, in order to globalize, exports started in Vietnam in 2018 and we are exporting to Southeast Asia, including Vietnam, Thailand, and Myanmar, in earnest in 2019. We are expecting that we can export to Russia around 2020 as we proceed with Russian licensing and branching.
- Main Markets
-
Austria
Croatia
Iran
Myanmar
Russia
South Korea
Thailand
Viet Nam
- Main Product
